The other day, Jamie Burr, an exercise physiologist in Canada, received a curious email from an overseas colleague. The researcher wanted to know if Burr, of the University of Guelph, had written a particular article.
Burr wondered:
Why are they questioning if I wrote something?
Turns out, something was real shady with the slim article.
Springer Nature has removed two studies that were published in its journal Cluster Computing and included a co-author who didn’t know that the papers existed until December 2020, years after they were published.
When David Cox noticed on Dec. 10, 2020 that two papers in the journal Cluster Computinglisted him as an author, he didn’t think much of it at first.
I have a common name, so it is not unheard of to have an article written by another David Cox assigned to my profile. I thought that was what these papers must have been at first, but then I opened the articles and saw my affiliation, email, and picture in them.
Shocked, Cox tweeted that “the whole thing is yucky.” The corresponding author on the two studies now says that he plans to withdraw the papers, and that a co-author made the decision to include Cox’s name and has been fired from his research position over the incident. Yesterday, on January 25, the publisher flagged one of the papers.
Cox, who is the IBM Director of the MIT-IBM Watson AI Lab, in Cambridge, Mass., learned about the articles after logging on to DBLP, a bibliography website that tracks articles published by computer scientists. “I check these sites from time to time to make sure everything is correct,” he said.
A medical journal has retracted two papers by a researcher with a penchant for fabricating co-authors.
According to the Singapore Medical Journal and earlier news reports, Shunjie Chua published the articles with two fictitious authors: Mark Pitts and Peter Lamark, whom he placed at Duke University and the University of Chicago.
The articles, “A simple, flexible and readily applicable method of boundary construction to prevent leech migration,” and “A handy way to handle hemoclips® in surgeries,” appeared in 2015. Per the retraction notice for the former:
On December 29, Jan Behrends, of the Institute of Physiology at the University of Freiburg, in Germany, was checking his Google Scholar profile when he saw his name on a paper — one he’d played no part in writing.
The article, “Microelectrochemical cell arrays for whole-cell currents recording through ion channel proteins based on trans-electroporation approach,” had appeared earlier that month in Analyst, a publication of the Royal Society of Chemistry. According to Behrends:
There’s a new publishing trend in town, says Mario Biagioli: Faking co-authors’ names. Biagioli, distinguished professor of law and science and technology studies and director of the Center for Innovation Studies at the University of California, Davis, writes in an article in Trends in Chemistry that it’s “the emergence of a new form of plagiarism that reflects the new metrics-based economy of scholarly publishing.” We asked him a few questions about what he’s found, and why authors might do this.
When the merde hits the fan, blame the translator. That’s Rule 1 of botched international diplomacy — and, evidently, botched international science.
Otolaryngology researchers in China have lost their 2018 paper in the American Journal of Translational Research for what they’re calling (with some degree of chutzpah) language barriers.
The article, “Therapeutic ultrasound potentiates the anti-nociceptive and anti-inflammatory effects of curcumin to postoperative pain via Sirt1/NF-κB signaling pathway,” came from group whose primary affiliation was the Second Military Medical University in Shanghai. (It hasn’t been cited, according to Clarivate’s Web of Science.) However, the list of authors also included several scientists in Germany.
What Caught Our Attention: PLOS ONE had a few reasons for retracting a 2015 paper about a treatment for kidney disease due to diabetes: For one, despite what the paper claims, the authors did not obtain ethical approval to conduct the reported animal experiments. In addition, the corresponding author had no idea the paper had been submitted and published. How could a corresponding author be kept in the dark? It turns out, the journal was given an incorrect email address for him, so he didn’t receive any communications around the paper. (One author apparently used a third party editing company.)Continue reading Caught Our Notice: Forged email for corresponding author dooms diabetes paper